AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Edwards Lifesciences Corporation

$84.37 -$0.96 (-1.13%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$86.77
Day Range
$83.81$87.75
Year Range
$72.3$96.29
Market Cap
48.58B
AVG Volume
4.38M
Trailing/Forward PE
48.49/24.92
PEG ratio
3.78
Dividend Yield
-
Next Earnings Date
2026-10-29
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
02B4B6B8B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EW Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q26.51B
26 Q16.3B
25 Q46.07B
25 Q35.88B
25 Q25.69B
25 Q15.54B
24 Q45.46B
24 Q35.34B
24 Q25.23B
24 Q15.14B
Net Income (USD) · TTM
02B4B6B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EW Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q21B
26 Q11.09B
25 Q41.07B
25 Q31.36B
25 Q24.14B
25 Q14.18B
24 Q44.17B
24 Q34.16B
24 Q21.47B
24 Q11.41B
Operating Income (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EW Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q21.83B
26 Q11.74B
25 Q41.62B
25 Q31.56B
25 Q21.49B
25 Q11.42B
24 Q41.38B
24 Q31.43B
24 Q21.42B
24 Q11.43B
EBITDA (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EW EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q21.54B
26 Q11.42B
25 Q41.39B
25 Q31.74B
25 Q21.78B
25 Q11.81B
24 Q41.75B
24 Q31.67B
24 Q21.66B
24 Q11.55B
Cash Flows (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EW Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q21.43B
26 Q11.09B
25 Q41.33B
25 Q3804.2M
25 Q2607.9M
25 Q1653.1M
24 Q4289.9M
24 Q3502.2M
24 Q2538.5M
24 Q1238.1M
EPS (USD) · TTM
0246824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EW EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q21.74
26 Q11.88
25 Q41.83
25 Q32.32
25 Q26.95
25 Q17
24 Q46.97
24 Q36.93
24 Q22.43
24 Q12.32
Expenses (USD) · TTM
01B2B3B4BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EW Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q23.58B
26 Q13.5B
25 Q43.42B
25 Q33.27B
25 Q23.12B
25 Q13.1B
24 Q43.1B
24 Q33.05B
24 Q23.02B
24 Q12.91B
Shares Outstanding (USD) · TTM
-500M0500M1B1.5B2BBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EW Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2290.7M
26 Q1247.6M
25 Q4-10.4M
25 Q3-62.5M
25 Q2994.6M
25 Q11.14B
24 Q4878M
24 Q31.35B
24 Q2629.5M
24 Q1485.4M
Employee Count
05K10K15K20K2016201720182019202020212022202320242025
EW Employee Count by quarter
PeriodEmployee Count
202516K
202415.8K
202319.8K
202217.3K
202115.7K
202014.9K
201913.9K
201812.8K
201712.2K
201611.1K
PE Ratio
0204060med 11.56Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW PE Ratio by quarter
PeriodPE Ratio
Sep 2648.39
Sep 2651.57
Aug 2651.74
Aug 2651.5
Aug 2652.54
Aug 2651.46
Jul 2645.62
Jul 2643.8
Jul 2645.44
Jul 2648.87
Jul 2650.02
Jun 2648.11
Jun 2646.3
Jun 2645.11
Jun 2645.56
May 2645.83
May 2645.46
May 2643.13
May 2642.38
May 2645.55
Apr 2645.64
Apr 2643.93
Apr 2642.24
Apr 2643.96
Mar 2643.03
Mar 2644.75
Mar 2644.37
Mar 2644.28
Feb 2646.9
Feb 2634.19
Feb 2632.51
Feb 2633.73
Jan 2634.86
Jan 2635.85
Jan 2636.14
Jan 2636.48
Jan 2636.56
Dec 2537.22
Dec 2536.71
Dec 2535.6
Dec 2536.93
Nov 2537.14
Nov 2536.48
Nov 2536.98
Nov 2535.73
Oct 2511.68
Oct 2510.78
Oct 2510.57
Oct 2510.47
Oct 2510.92
Sep 2510.8
Sep 2510.54
Sep 2510.99
Sep 2511.46
Aug 2511.52
Aug 2511.59
Aug 2511.09
Aug 2511.1
Aug 2511.14
Jul 2511.24
Jul 2510.74
Jul 2510.96
Jul 2510.79
Jun 2510.99
Jun 2510.37
Jun 2510.56
Jun 2510.89
May 2510.99
May 2510.53
May 2510.96
May 2510.35
May 2510.69
Apr 2510.75
Apr 2510.11
Apr 259.81
Apr 259.81
Mar 2510.02
Mar 259.96
Mar 259.8
Mar 259.94
Feb 2510.12
Feb 2510.53
Feb 2510.95
Feb 2510.11
Jan 2510.41
Jan 259.91
Jan 2510.03
Jan 2510.55
Jan 2510.62
Dec 2410.87
Dec 2410.75
Dec 2410.54
Dec 2410.28
Nov 2410.25
Nov 2410.13
Nov 249.74
Nov 249.52
Nov 2427.66
Oct 2428.41
Oct 2428.77
Free Cash Flow Yield
0%1%2%3%med 1.45%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 262.95%
Sep 262.77%
Aug 262.76%
Aug 262.77%
Aug 262.72%
Aug 262.77%
Jul 262.19%
Jul 262.28%
Jul 262.19%
Jul 262.04%
Jul 261.99%
Jun 262.07%
Jun 262.15%
Jun 262.21%
Jun 262.19%
May 262.18%
May 262.19%
May 262.31%
May 262.35%
May 262.74%
Apr 262.73%
Apr 262.84%
Apr 262.95%
Apr 262.84%
Mar 262.9%
Mar 262.79%
Mar 262.81%
Mar 262.82%
Feb 262.66%
Feb 261.72%
Feb 261.81%
Feb 261.75%
Jan 261.69%
Jan 261.64%
Jan 261.63%
Jan 261.62%
Jan 261.61%
Dec 251.58%
Dec 251.61%
Dec 251.66%
Dec 251.6%
Nov 251.59%
Nov 251.62%
Nov 251.59%
Nov 251.65%
Oct 251.26%
Oct 251.36%
Oct 251.39%
Oct 251.4%
Oct 251.34%
Sep 251.36%
Sep 251.39%
Sep 251.34%
Sep 251.28%
Aug 251.27%
Aug 251.27%
Aug 251.32%
Aug 251.32%
Aug 251.4%
Jul 251.39%
Jul 251.45%
Jul 251.43%
Jul 251.45%
Jun 251.42%
Jun 251.51%
Jun 251.48%
Jun 251.44%
May 251.42%
May 251.48%
May 251.43%
May 251.51%
May 250.65%
Apr 250.65%
Apr 250.69%
Apr 250.71%
Apr 250.71%
Mar 250.69%
Mar 250.7%
Mar 250.71%
Mar 250.7%
Feb 250.69%
Feb 251.15%
Feb 251.1%
Feb 251.2%
Jan 251.16%
Jan 251.22%
Jan 251.21%
Jan 251.15%
Jan 251.14%
Dec 241.11%
Dec 241.12%
Dec 241.15%
Dec 241.18%
Nov 241.18%
Nov 241.19%
Nov 241.24%
Nov 241.27%
Nov 241.32%
Oct 241.29%
Oct 241.27%
Price to Sales
77.588.59med 7.99Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW Price to Sales by quarter
PeriodPrice to Sales
Sep 267.47
Sep 267.96
Aug 267.98
Aug 267.95
Aug 268.11
Aug 267.94
Jul 267.91
Jul 267.59
Jul 267.88
Jul 268.47
Jul 268.67
Jun 268.34
Jun 268.03
Jun 267.82
Jun 267.9
May 267.95
May 267.88
May 267.48
May 267.35
May 268.03
Apr 268.05
Apr 267.75
Apr 267.45
Apr 267.75
Mar 267.59
Mar 267.89
Mar 267.83
Mar 267.81
Feb 268.27
Feb 267.93
Feb 267.54
Feb 267.82
Jan 268.09
Jan 268.31
Jan 268.38
Jan 268.46
Jan 268.48
Dec 258.63
Dec 258.51
Dec 258.26
Dec 258.57
Nov 258.61
Nov 258.46
Nov 258.58
Nov 258.29
Oct 258.51
Oct 257.86
Oct 257.71
Oct 257.63
Oct 257.96
Sep 257.87
Sep 257.68
Sep 258.01
Sep 258.36
Aug 258.4
Aug 258.45
Aug 258.08
Aug 258.09
Aug 258.41
Jul 258.48
Jul 258.11
Jul 258.27
Jul 258.14
Jun 258.29
Jun 257.82
Jun 257.96
Jun 258.21
May 258.29
May 257.95
May 258.27
May 257.81
May 258.18
Apr 258.22
Apr 257.73
Apr 257.5
Apr 257.5
Mar 257.67
Mar 257.62
Mar 257.49
Mar 257.6
Feb 257.74
Feb 258.2
Feb 258.53
Feb 257.87
Jan 258.11
Jan 257.72
Jan 257.81
Jan 258.22
Jan 258.27
Dec 248.47
Dec 248.37
Dec 248.2
Dec 248
Nov 247.98
Nov 247.89
Nov 247.58
Nov 247.41
Nov 247.78
Oct 247.99
Oct 248.1
EV/EBITDA
2025303540med 24.63Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2629.27
Sep 2631.34
Aug 2631.46
Aug 2631.3
Aug 2631.98
Aug 2631.27
Jul 2633
Jul 2631.59
Jul 2632.86
Jul 2635.5
Jul 2636.38
Jun 2634.92
Jun 2633.52
Jun 2632.61
Jun 2632.95
May 2633.16
May 2632.88
May 2631.09
May 2630.51
May 2632.5
Apr 2632.57
Apr 2631.25
Apr 2629.95
Apr 2631.28
Mar 2630.56
Mar 2631.88
Mar 2631.59
Mar 2631.52
Feb 2633.54
Feb 2624.97
Feb 2623.66
Feb 2624.62
Jan 2625.5
Jan 2626.28
Jan 2626.51
Jan 2626.77
Jan 2626.84
Dec 2527.35
Dec 2526.95
Dec 2526.08
Dec 2527.13
Nov 2527.29
Nov 2526.77
Nov 2527.16
Nov 2526.19
Oct 2525.26
Oct 2523.17
Oct 2522.69
Oct 2522.46
Oct 2523.49
Sep 2523.22
Sep 2522.61
Sep 2523.65
Sep 2524.76
Aug 2524.89
Aug 2525.05
Aug 2523.88
Aug 2523.91
Aug 2523.97
Jul 2524.18
Jul 2523.04
Jul 2523.55
Jul 2523.14
Jun 2523.6
Jun 2522.18
Jun 2522.61
Jun 2523.38
May 2523.61
May 2522.56
May 2523.53
May 2522.13
May 2523.65
Apr 2523.78
Apr 2522.26
Apr 2521.54
Apr 2521.52
Mar 2522.05
Mar 2521.9
Mar 2521.5
Mar 2521.85
Feb 2522.29
Feb 2523.99
Feb 2525.03
Feb 2522.94
Jan 2523.69
Jan 2522.45
Jan 2522.73
Jan 2524.04
Jan 2524.21
Dec 2424.83
Dec 2424.53
Dec 2424
Dec 2423.36
Nov 2423.3
Nov 2422.98
Nov 2422.01
Nov 2421.46
Nov 2423.66
Oct 2424.32
Oct 2424.64
Price/Operating Cashflow
20406080100med 49.89Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2628.27
Sep 2630.12
Aug 2630.23
Aug 2630.08
Aug 2630.69
Aug 2630.06
Jul 2636.69
Jul 2635.23
Jul 2636.55
Jul 2639.31
Jul 2640.23
Jun 2638.7
Jun 2637.24
Jun 2636.28
Jun 2636.65
May 2636.86
May 2636.57
May 2634.69
May 2634.09
May 2630.56
Apr 2630.62
Apr 2629.47
Apr 2628.33
Apr 2629.49
Mar 2628.87
Mar 2630.02
Mar 2629.77
Mar 2629.7
Feb 2631.46
Feb 2645.88
Feb 2643.63
Feb 2645.26
Jan 2646.79
Jan 2648.11
Jan 2648.5
Jan 2648.95
Jan 2649.07
Dec 2549.94
Dec 2549.26
Dec 2547.77
Dec 2549.56
Nov 2549.84
Nov 2548.95
Nov 2549.63
Nov 2547.95
Oct 2560.89
Oct 2556.2
Oct 2555.12
Oct 2554.6
Oct 2556.91
Sep 2556.31
Sep 2554.95
Sep 2557.28
Sep 2559.77
Aug 2560.07
Aug 2560.43
Aug 2557.79
Aug 2557.86
Aug 2553.14
Jul 2553.59
Jul 2551.23
Jul 2552.28
Jul 2551.44
Jun 2552.39
Jun 2549.45
Jun 2550.34
Jun 2551.92
May 2552.39
May 2550.23
May 2552.25
May 2549.35
May 2582.28
Apr 2582.7
Apr 2577.8
Apr 2575.48
Apr 2575.44
Mar 2577.12
Mar 2576.63
Mar 2575.36
Mar 2576.49
Feb 2577.89
Feb 2554.28
Feb 2556.42
Feb 2552.1
Jan 2553.65
Jan 2551.09
Jan 2551.68
Jan 2554.37
Jan 2554.74
Dec 2456.02
Dec 2455.4
Dec 2454.3
Dec 2452.97
Nov 2452.84
Nov 2452.2
Nov 2450.18
Nov 2449.05
Nov 2446.95
Oct 2448.23
Oct 2448.85
Price to Book
44.555.56med 4.55Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EW Price to Book by quarter
PeriodPrice to Book
Sep 264.53
Sep 264.83
Aug 264.85
Aug 264.83
Aug 264.92
Aug 264.82
Jul 264.83
Jul 264.63
Jul 264.81
Jul 265.17
Jul 265.29
Jun 265.09
Jun 264.9
Jun 264.77
Jun 264.82
May 264.85
May 264.81
May 264.56
May 264.48
May 264.72
Apr 264.72
Apr 264.55
Apr 264.37
Apr 264.55
Mar 264.45
Mar 264.63
Mar 264.59
Mar 264.58
Feb 264.85
Feb 264.57
Feb 264.35
Feb 264.51
Jan 264.66
Jan 264.79
Jan 264.83
Jan 264.88
Jan 264.89
Dec 254.98
Dec 254.91
Dec 254.76
Dec 254.94
Nov 254.97
Nov 254.88
Nov 254.94
Nov 254.78
Oct 254.56
Oct 254.21
Oct 254.13
Oct 254.09
Oct 254.27
Sep 254.22
Sep 254.12
Sep 254.29
Sep 254.48
Aug 254.5
Aug 254.53
Aug 254.33
Aug 254.34
Aug 254.57
Jul 254.61
Jul 254.4
Jul 254.49
Jul 254.42
Jun 254.5
Jun 254.25
Jun 254.33
Jun 254.46
May 254.5
May 254.32
May 254.49
May 254.24
May 254.43
Apr 254.46
Apr 254.19
Apr 254.07
Apr 254.07
Mar 254.16
Mar 254.13
Mar 254.06
Mar 254.12
Feb 254.2
Feb 254.55
Feb 254.73
Feb 254.37
Jan 254.5
Jan 254.29
Jan 254.34
Jan 254.56
Jan 254.59
Dec 244.7
Dec 244.65
Dec 244.56
Dec 244.44
Nov 244.43
Nov 244.38
Nov 244.21
Nov 244.12
Nov 245.42
Oct 245.57
Oct 245.64
Edwards Lifesciences Corporation
EW
Stockpicker

Video analysis: EW

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: EW

Edwards Lifesciences Comments on TAVR National Coverage Decision

businesswire.com · 10 Sep 2026

Edwards Lifesciences Comments on TAVR National Coverage Decision

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare & Medicaid Services (CMS):“Edwards is pleased that this updated policy represents an important step toward improving and expanding patient access to TAVR while reinforcing the value of a multidisciplinary Heart Team. Aortic stenosis is a serious, pro.

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

prnewswire.com · 7 Sep 2026

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

businesswire.com · 2 Sep 2026

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026.Bernard Zovighian, chief executive officer, is scheduled to present at 10:00 a.m. ET. Doretta Mistras, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessibl.

128,603 Shares in Edwards Lifesciences Corporation $EW Acquired by Beacon Pointe Advisors LLC

defenseworld.net · 29 Aug 2026

128,603 Shares in Edwards Lifesciences Corporation $EW Acquired by Beacon Pointe Advisors LLC

Beacon Pointe Advisors LLC bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 128,603 shares of the medical research company's stock, valued at approximately $11,632,000. A number of

Is EW Overvalued? DCF Says Worth $53

gurufocus.com · 26 Aug 2026

Is EW Overvalued? DCF Says Worth $53

On August 26, 2026, we delve into the DCF analysis for Edwards Lifesciences Corp (EW), a company that has seen a price performance of +12.4% over the past year

Bank of Nova Scotia Takes Position in Edwards Lifesciences Corporation $EW

defenseworld.net · 26 Aug 2026

Bank of Nova Scotia Takes Position in Edwards Lifesciences Corporation $EW

Bank of Nova Scotia bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 60,417 shares of the medical research company's stock, valued at approximately $5,465,000. Several other hedge funds also recently made

37,702 Shares in Edwards Lifesciences Corporation $EW Bought by EP Wealth Advisors LLC

defenseworld.net · 23 Aug 2026

37,702 Shares in Edwards Lifesciences Corporation $EW Bought by EP Wealth Advisors LLC

EP Wealth Advisors LLC bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 37,702 shares of the medical research company's stock, valued at approximately $3,410,000. Other institutional investors and hedge

B. Metzler seel. Sohn & Co. AG Buys Shares of 41,753 Edwards Lifesciences Corporation $EW

defenseworld.net · 22 Aug 2026

B. Metzler seel. Sohn & Co. AG Buys Shares of 41,753 Edwards Lifesciences Corporation $EW

B. Metzler seel. Sohn and Co. AG acquired a new position in Edwards Lifesciences Corporation (NYSE: EW) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 41,753 shares of the medical research company's stock, valued at approximately $3,777,000. Several other hedge

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.